GSK plc (LSE:GSK) — Stock Price

GBX1750.00 GBX
▲ 0.84% today

GSK plc (LSE:GSK) is currently trading at GBX1750.00 GBX, up 0.84% today. Over the past 52 weeks, shares have ranged between GBX1620.00 and GBX2268.00. This page tracks GSK plc's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see how efficiently does GSK plc generate cash.

GSK plc (GSK) Stock Price Chart — Daily History & Trading Volume

The chart below tracks GSK plc's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

GSK plc Income Statement — Revenue, Profit & Earnings by Year

GSK plc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue GBX32.67 Billion GBX31.38 Billion GBX30.33 Billion GBX29.32 Billion GBX24.70 Billion
Cost of Revenue GBX8.97 Billion GBX9.48 Billion GBX9.08 Billion GBX9.86 Billion GBX8.35 Billion
Gross Profit GBX23.70 Billion GBX21.90 Billion GBX21.25 Billion GBX19.46 Billion GBX16.34 Billion
Research & Development GBX7.51 Billion GBX5.50 Billion GBX5.25 Billion GBX4.84 Billion GBX4.39 Billion
SG&A GBX9.09 Billion GBX11.02 Billion GBX9.38 Billion GBX8.37 Billion GBX10.97 Billion
Total Operating Expenses GBX16.53 Billion GBX16.24 Billion GBX14.26 Billion GBX12.78 Billion GBX10.94 Billion
Operating Income GBX7.17 Billion GBX5.66 Billion GBX6.99 Billion GBX6.68 Billion GBX5.41 Billion
EBITDA GBX11.88 Billion GBX6.67 Billion GBX9.14 Billion GBX8.63 Billion GBX6.45 Billion
EBIT GBX8.11 Billion GBX4.12 Billion GBX6.84 Billion GBX6.48 Billion GBX4.33 Billion
Interest Expense GBX701.00 Million GBX644.00 Million GBX775.00 Million GBX852.00 Million GBX765.00 Million
Income Before Tax GBX7.40 Billion GBX3.48 Billion GBX6.06 Billion GBX5.63 Billion GBX3.60 Billion
Income Tax Expense GBX1.11 Billion GBX526.00 Million GBX756.00 Million GBX707.00 Million GBX83.00 Million
Net Income GBX5.72 Billion GBX2.58 Billion GBX4.93 Billion GBX14.96 Billion GBX4.38 Billion

GSK plc Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes GSK plc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets GBX61.12 Billion GBX59.46 Billion GBX59.01 Billion GBX60.15 Billion GBX79.10 Billion
Total Current Assets GBX17.51 Billion GBX17.00 Billion GBX18.64 Billion GBX20.77 Billion GBX18.67 Billion
Cash & Equivalents — — — — —
Short-term Investments GBX9.00 Million GBX21.00 Million GBX2.25 Billion GBX4.15 Billion GBX61.00 Million
Net Receivables GBX6.58 Billion GBX6.00 Billion GBX6.46 Billion GBX6.22 Billion GBX7.54 Billion
Inventory GBX5.92 Billion GBX5.67 Billion GBX5.50 Billion GBX5.15 Billion GBX5.78 Billion
Property, Plant & Equipment — — — GBX9.62 Billion GBX10.67 Billion
Goodwill GBX7.02 Billion GBX6.98 Billion GBX6.81 Billion GBX7.05 Billion GBX10.55 Billion
Total Liabilities GBX45.16 Billion GBX46.38 Billion GBX46.21 Billion GBX50.05 Billion GBX57.76 Billion
Total Current Liabilities GBX21.39 Billion GBX21.70 Billion GBX21.07 Billion GBX22.81 Billion GBX23.67 Billion
Long-term Debt GBX14.02 Billion GBX13.70 Billion GBX14.15 Billion GBX16.19 Billion GBX19.76 Billion
Net Debt GBX14.57 Billion GBX13.29 Billion GBX15.27 Billion GBX17.46 Billion GBX20.10 Billion
Total Stockholder Equity GBX16.38 Billion GBX13.67 Billion GBX13.35 Billion GBX10.60 Billion GBX15.05 Billion
Retained Earnings GBX10.21 Billion GBX7.80 Billion GBX7.24 Billion GBX4.36 Billion GBX7.94 Billion

GSK plc Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how GSK plc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow GBX7.30 Billion GBX6.55 Billion GBX6.77 Billion GBX7.40 Billion GBX7.95 Billion
Capital Expenditures GBX1.35 Billion GBX2.98 Billion GBX2.34 Billion GBX2.26 Billion GBX2.93 Billion
Free Cash Flow GBX5.96 Billion GBX3.57 Billion GBX4.42 Billion GBX5.14 Billion GBX5.02 Billion
Investing Cash Flow GBX-5.85 Billion GBX-1.23 Billion GBX-1.59 Billion GBX-8.77 Billion GBX-1.78 Billion
Financing Cash Flow GBX-1.63 Billion GBX-4.73 Billion GBX-5.64 Billion GBX823.00 Million GBX-7.59 Billion
Dividends Paid GBX2.56 Billion GBX2.44 Billion GBX2.25 Billion GBX3.47 Billion GBX4.00 Billion
Stock-Based Compensation GBX374.00 Million GBX344.00 Million GBX307.00 Million GBX346.00 Million GBX367.00 Million
Depreciation GBX3.78 Billion GBX2.55 Billion GBX2.29 Billion GBX2.30 Billion GBX2.52 Billion
Change in Cash GBX-473.00 Million GBX545.00 Million GBX-567.00 Million GBX-394.00 Million GBX-1.44 Billion

GSK plc Earnings History — EPS Actual vs. Analyst Estimates

Track GSK plc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 28, 2026 — 0.53 —
Jul 28, 2026 0.51 0.47 +8.51%
Apr 28, 2026 0.47 0.47 -0.15%
Feb 03, 2026 0.26 0.25 +0.04%
Oct 29, 2025 0.55 0.46 +19.57%
Jul 30, 2025 0.47 0.42 +11.90%
Apr 30, 2025 0.45 0.40 +12.50%
Feb 05, 2025 0.23 0.19 +21.05%